Drug intelligence / Profile preview

Compound Pien Tze Huang Buccal Tablet

Development stage
Unknown
Lead developer
Zhangzhou Pien Tze Huang Pharmaceutical
Administration
Buccal
01

Overview

Compound Pien Tze Huang Buccal Tablet (Fufang Pianzaihuang Hanpian) is a traditional Chinese medicine (TCM) formulation developed and manufactured by Zhangzhou Pien Tze Huang Pharmaceutical Co., Ltd. It is a multi-component herbal product containing Herba Wedeliae, Herba Sarcandrae, Radix Scrophulariae, Radix Ophiopogonis, Radix Glycyrrhizae, Pien Tze Huang powder, and Mentholum. The formulation is indicated for the treatment of acute and chronic pharyngitis (faucitis) resulting from the upward invasion of wind-fire and excessive heat in the lung and stomach. It works by clearing internal heat, detoxifying, relieving throat pain, and moistening the throat. As a TCM formulation, it does not have a specified single molecular mechanism of action or biological target, but rather exerts its therapeutic effects through the combined action of its multiple herbal components.

Brand names
Compound Pien Tze Huang Buccal Tablet
Other names
Fufang Pianzaihuang HanpianPien Tze Huang buccal tablet
02

Targets

TNFA (Tumor necrosis factor alpha (soluble))ERBB2 (Erb-b2 receptor tyrosine kinase 2)

Beyond the preview

Go deeper on Compound Pien Tze Huang Buccal Tablet.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Compound Pien Tze Huang Buccal Tablet.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call